Kurt Kamrud has joined Harris Vaccines as vice president for research and chief scientific officer. He will oversee vaccine development and be responsible for interactions with USDA. Kamrud was previously with AlphaVax, in Research Triangle Park, N.C.

Kamrud is an infectious disease expert. After completing his doctorate degree in microbiology, he conducted research at the U.S. Army Medical Research Institute for Infectious Diseases, developing alphavirus replicon-based vaccines. 

Prior to joining Harris Vaccines, Kamrud served as the director of discovery at AlphaVax, the commercial developer of the alphavirus replicon vaccine system used at Harris.